MEDS Latest Headlines

DataMeds AI Terminates Letter of Intent Amid Market Conditions

at www.tipranks.com (Thu, 5-Nov 6:38 AM)

MEDS Highlights Humana Medicaid Policy Adding ChemoFx for Gynecologic Cancers, Citing $6,206 ICER per Life-Year Saved in Recurrent EOC

Market Chameleon (Mon, 12-Oct 7:06 AM)

DataMeds AI (MEDS) jumps after Corexa Pharmacy tops $1 million in preliminary September revenue

Market Chameleon (Thu, 1-Oct 11:35 AM)

DataMeds AI Highlights Corexa Pharmacy Revenue Above $1 Million as Rebranding and Adjunct Products Gain Traction

Market Chameleon (Thu, 1-Oct 7:36 AM)

DataMEDS AI Spotlights Patient-Owned Health Data Ahead of September 28 Telehealth Summit Talk

Market Chameleon (Mon, 28-Sep 11:32 AM)

DataMeds AI Ties GLP-1 Support to a New Pharmacy Network With First Site Named

Market Chameleon (Mon, 28-Sep 7:05 AM)

DataMEDS AI Sets September 28 Summit Talk on Patient Ownership of Health Data

Market Chameleon (Fri, 25-Sep 11:36 AM)

DataMeds AI (MEDS) settles debt-and-receivables litigation, eliminating about $19 million in liabilities

Market Chameleon (Mon, 21-Sep 11:04 AM)

DataMeds AI (MEDS) settles legacy debt litigation, clearing about $19 million in balance-sheet liabilities

Market Chameleon (Fri, 18-Sep 9:52 AM)

DataMeds AI settles legacy Wellgistics dispute, wiping about $19 million in liabilities and retiring 364,099 shares

Market Chameleon (Fri, 18-Sep 7:28 AM)

MEDS jumps after a $1.5 million Helomics acquisition adds a CLIA/CAP-certified oncology lab

Market Chameleon (Wed, 16-Sep 9:51 AM)